India’s AI‑enabled, anti‑FWA, interoperable roadmap is not a “payer‑only” agenda; it will structurally rewire business models for private hospitals, pharma, devices and diagnostics. These sectors will need to pivot from volume‑driven, opaque practices to data‑disciplined, value‑and‑outcomes‑driven strategies if they want to stay preferred partners in a tighter, analytics‑led health‑financing regime.[1][2][3] What changes for private hospitals…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
